{"name":"Merrimack Pharmaceuticals","slug":"merrimack-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQY0sxS2liejNUREFxdnV1ei1ESHhIWGZjWUVzb2xETlhwQzY1SGR2cmhPLVR3UXlleUV6eE9TdFJFSzBtVGRsdlpRUUVkUGM1S1cwbmJrbU13OWc3bVhlbGZ5aFpWNTJJaExSR3hQeFR6Z1p5cUFnbnYtT1E4a3ZYVEhhUGNmMDdHV3B6WDlwemtYbmUxMlFXcnUzRHZ5YmxmVmxpMk56aHB2YjRQcktTdGxFSkYwSExWRWJTTklIZ181R296TjFQVEpWb0RERU1yQUNRQTVXMlNYcW5wUjJGdWNzTzVHWG4xTTM3bGwwcG1pbFZ2cV9aYTJNbEVVMWxEOTFkT214Ry1mX050ek4zOWM0VlYxdS01SHByYm96Wk9OMTFoNUw5dlZfM2tXMHNmVUllVWV6b0ZZMHhP?oc=5","date":"2024-05-10","type":"regulatory","source":"Business Wire","summary":"Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock - Business Wire","headline":"Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amou","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQWZLajhUeE1KUWNTOHZMdENlcC1EZklXZnFrM0lqckJpaEV2ZG83NXFzVjdRU2ttMlRTRXRsUDdBOEtmWnJLcHUxejdTd3p3amF1WlRHd1VfQ3hOODdvTUJ1MXVuVVFBTDFvU2FXNDRwaGNJYk8tUDJKbThFS3d6MzlHTzJwNE1mUmx0WmYyNTBuMndFRlJBRGl3c2lYUXg0YUl0Z0ViQ3dUUjRLNDZRTXBGeS1PQ05HVHU0?oc=5","date":"2024-03-27","type":"pipeline","source":"Business Wire","summary":"Merrimack Receives $225 Million Milestone Payment from Ipsen - Business Wire","headline":"Merrimack Receives $225 Million Milestone Payment from Ipsen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPZlNBV243Yk5aNEdyYkdpY3lZaF92OVF0YlgwcEdJUkNSMm9lVUdtUWExU1U1TUVwcFFZclVVTk9KMzhLa1I4MWcxdjZCRlB2d28tcUpMQVA4V2dad0VzTzdDdXZNYkhKSTRVNmE1c3VtTjg0Z2NMZE9JdVlYcnhsblJlN2ZPSmdFN3VQQnA4SEc?oc=5","date":"2024-03-04","type":"pipeline","source":"Yahoo Finance","summary":"Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company - Yahoo Finance","headline":"Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOV1JxMVpYVktDSjR5Q05OVS1EWHkxZlBaQnk0WGdCUDV2U3duOThORmRVVUpFQmFSX08wR3cxZk02MXVQd0d6SjZ5WjUwX29UX2RpZXR6czJXck5lcG9GVHhSZmVCNHYwaWg0c3A5OE1ScGFjTmluOTRQQTZUZkdvV0xrV0oyNElGT2Nsd3ZzckFlTXZjdjBmTVd3?oc=5","date":"2022-11-09","type":"trial","source":"statnews.com","summary":"Shares of Merrimack, a dormant drugmaker, soar after cancer drug succeeds in trial - statnews.com","headline":"Shares of Merrimack, a dormant drugmaker, soar after cancer drug succeeds in trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOUktFTnJnYmVObTV4ZkNWRnYwcHRRMGotU2RWRnpXcGlmZVFPVUtETm9DUDR0UkZxRFRMbmp3ejVhWmxHNjByMWRKdkl4TnV6dW1fa0x3X0sxVVdvbUx4dWRQaXcwUVZHbzRoMWV3bktSMFdTd2JhSjR2T0JpWXc5XzFzeWROOUpEeGd3blJhRG1BNjJ1SzR3?oc=5","date":"2022-11-09","type":"pipeline","source":"BioPharma Dive","summary":"Ipsen drug shows benefit in pancreatic cancer, lifting shares of ghost company - BioPharma Dive","headline":"Ipsen drug shows benefit in pancreatic cancer, lifting shares of ghost company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1zY0QxNDFiMldhM290Q0wxS3Qtb1ZwTGVUTkVneGhZZ1Vjd2t4blhlZHdqNmFGMHRYX2pfN3Q4WlRSYUdVOHhkV0tUUXdiTGdLZ2I2amRRR2RoWWJh?oc=5","date":"2020-11-05","type":"earnings","source":"Stock Titan","summary":"Latest MACK News - Merrimack Reports Third Quarter 2020 Financ... - Stock Titan","headline":"Latest MACK News - Merrimack Reports Third Quarter 2020 Financ...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOdWxUeVAzQjE4NkxCODVzT1VOZVYzaVVpbnh1N2JZSHZ4Z09ZVm5oMTlfUTFDV0haRVRFamJOeTY4ZnBLUlJwTVdLZlVTYXY2MVJXY1lRSmdleTJrbzBvWkF1U19QR3p4c1NIdU5SVHdhaXpTcldKWGdLWXJJY09nQUFfNGpQcjZPR2laeEdoUXdXRkNvRkVCV29tTkVZV3RyQ3h5MGFtOXVQOGJ1eVo4dQ?oc=5","date":"2019-07-10","type":"pipeline","source":"Fierce Biotech","summary":"After exiting troubled Merrimack, former CEO becomes new chief at Yumanity - Fierce Biotech","headline":"After exiting troubled Merrimack, former CEO becomes new chief at Yumanity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQczRadHNOSzZXekZZd2ZKaW9iQm84QXJTSFA3VnJvbk1fcXl4Q2NBaHZmYWlELWUzS0wtU3JUc0RuUC1oS1YwNThFSEkwSDU1NWhKdW5CMnRKRk9LRmFoTVpRS1hLSDRTOWsxTHZRLUlsRGZsY3psV2J2LUhTZ2QzRWFhUVNvVGRhZ1NhdXR5d0JGcUxQbXZEYWNPU2FHeDNNU2RndlhPQ1o1Vi1fQVB0dzl3M2pFMlk2?oc=5","date":"2019-04-05","type":"pipeline","source":"Fierce Biotech","summary":"Merrimack 0 for 3 as it dumps cancer drug over safety fears, axes staffers (again) - Fierce Biotech","headline":"Merrimack 0 for 3 as it dumps cancer drug over safety fears, axes staffers (again)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPdkg2WHdlRU5FdzhOdURhbS1QWUxzcDd0N3JCZXM2NlUybXJZOU1qRzkxLWlodllxZkx6WWxjdFR2em5fV3BPVUE5MGdaQVhYS3EtVmlhWWE1M1RKQzRScmRGclg5QXpuY0Ztc0dCRU1pU1Y2ek1qUW44WHpRMUJjdHdnczE0cHBQZWNNemFidFpNZGw3RmpuVHFsbHJ1QWM4MmxsQUJ3c3VLZ1dGS1RkeA?oc=5","date":"2017-01-09","type":"deal","source":"Fierce Pharma","summary":"Ipsen gets U.S. manufacturing with $1.25B deal for Merrimack Pharmaceuticals - Fierce Pharma","headline":"Ipsen gets U.S. manufacturing with $1.25B deal for Merrimack Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNQ2gtZW9PYWFmNXVuT2tUQ1F6MWFmamNTVXRJdnJnRTJmeXNDYVFyY0w4X1ZndjlVMFpNbDBkbl9QMEduRHhGM3JQRm5ieHQ5Q2psa3hzQ2lLdV8ySE9KbmlrMF85b3pUc0FLb1BGTENWNTlvRGY5WmxFeWk1RktPcUdURV9wZ2Jf?oc=5","date":"2017-01-09","type":"pipeline","source":"Pharmafile","summary":"Merrimack sells off drug for $1 billion and cuts workforce by 80% - Pharmafile","headline":"Merrimack sells off drug for $1 billion and cuts workforce by 80%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOY0hyVTNSZkVqRHZQYjVFaVFWdHZ1aXF1bGxmMFdMemY3Y0tTRXhpZWM3eFg4M3FwbGwyaU1KV2tET080ZEVIeFJmdXpYNmR6T0JKMmR2MlNDZ0JHajRnX2FoUHVESGlCTl9jVnVxMk95MVFKVzA1VDRkbktwdVlEY3hVQURJMVZvSm9OZmZn?oc=5","date":"2017-01-08","type":"pipeline","source":"BioPharma Dive","summary":"JPM: Ipsen snatches up Merrimack’s Onivyde for $575M - BioPharma Dive","headline":"JPM: Ipsen snatches up Merrimack’s Onivyde for $575M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPRGZJMVNDTjFhWWgwUFUwM2FXY3VzcWt1UnVFNnZYLThxaDNFeWsyZUVDd01sVU84T1lXMElYOHU5TzR3OVJlMDZRLUpLdHVqSkdJam9RRlViZDYyeGlaT09MV3k5WjBkd2V2QTFPY1EtaEloTC1MRFR3dmV2ZmpVczJVOW5VRlZrMWN4WkhTbjgxclFnbUs0WlhLY1FkX3FK?oc=5","date":"2016-10-03","type":"earnings","source":"Pharmafile","summary":"Merrimack Pharmaceuticals’ CEO resigns and workforce cut by nearly a quarter - Pharmafile","headline":"Merrimack Pharmaceuticals’ CEO resigns and workforce cut by nearly a quarter","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}